Michael Parini
2017
Compensation breakdown
Non-Equity Incentive Plan | $788,655 |
---|---|
Option Awards | $1,332,316 |
Salary | $694,519 |
Stock Awards | $3,150,020 |
Other | $13,110 |
Total | $5,978,620 |
Parini received $3.2M in stock awards, accounting for 53% of the total pay in 2017.
Parini also received $788.7K in non-equity incentive plan, $1.3M in option awards, $694.5K in salary and $13.1K in other compensation.
Rankings
In 2017, Michael Parini's compensation ranked 1,472nd out of 14,666 executives tracked by ExecPay. In other words, Parini earned more than 90.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,472 | 90th |
Manufacturing | 494 | 91st |
Chemicals And Allied Products | 132 | 94th |
Drugs | 95 | 95th |
Pharmaceutical Preparations | 74 | 94th |
Parini's colleagues
We found six more compensation records of executives who worked with Michael Parini at Vertex Pharmaceuticals in 2017.
2017
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2017
Ian Smith
Vertex Pharmaceuticals
Chief Operating Officer
2017
David Altshuler
Vertex Pharmaceuticals
Chief Scientific Officer
2017
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Regulatory Officer
2017
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2017
Thomas Graney
Vertex Pharmaceuticals